Rankings
▼
Calendar
TLSI Q2 2024 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
TLSI
TriSalus Life Sciences, Inc.
$175M
Q2 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$7M
+59.7% YoY
Gross Profit
$6M
87.6% margin
Operating Income
-$8M
-111.0% margin
Net Income
-$4M
-58.8% margin
EPS (Diluted)
$-0.21
QoQ Revenue Growth
+14.0%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$32M
Total Liabilities
$57M
Stockholders' Equity
-$24M
Cash & Equivalents
$16M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$5M
+59.7%
Gross Profit
$6M
$4M
+68.0%
Operating Income
-$8M
-$11M
+28.5%
Net Income
-$4M
-$14M
+69.0%
← FY 2024
All Quarters
Q3 2024 →